Search

Search Constraints

You searched for: Author/Creator Voskoboynik, Mark

Search Results

2. A phase 1 dose‐escalation study of the poly(ADP‐ribose) polymerase inhibitor senaparib in Australian patients with advanced solid tumors. Issue 7 (31st January 2023)

4. Clinicopathological characteristics associated with BRAFK601E and BRAFL597 mutations in melanoma. (17th January 2016)

6. Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018). Issue 1 (13th February 2019)

7. First‐in‐human phase 1 study of MK‐1248, an anti–glucocorticoid‐induced tumor necrosis factor receptor agonist monoclonal antibody, as monotherapy or with pembrolizumab in patients with advanced solid tumors. Issue 22 (18th August 2020)

10. Prospective analysis of 895 patients on a UK Genomics Review Board. Issue 2 (21st March 2019)